Pharmacotherapy of ADHD in Slovenia: realities and perspectives

被引：4

作者：

Stuhec, Matej ^{[1
,2
,3
]}

机构：

[1] Ormoz Psychiat Hosp, Dept Clin Pharm, Ljubljana, Slovenia

[2] Fac Pharm Ljubljana, Ljubljana, Slovenia

[3] Ptujska Cesta 33, Ormoz, Slovenia

来源：

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY | 2016年 / 25卷 / 04期

关键词：

ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; ADOLESCENTS; CHILDREN; METHYLPHENIDATE; PREVALENCE; LISDEXAMFETAMINE;

D O I：

10.1007/s00787-015-0811-4

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

[No abstract available]

引用

页码：455 / 457

页数：3

共 11 条

[1] Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology [J].

Bolea-Alamanac, Blanca ;

Nutt, David J. ;

Adamou, Marios ;

Asherson, Phillip ;

Bazire, Stephen ;

Coghill, David ;

Heal, David ;

Mueller, Ulrich ;

Nash, John ;

Santosh, Paramala ;

Sayal, Kapil ;

Sonuga-Barke, Edmund J. S. ;

Young, Susan J. .

JOURNAL OF PSYCHOPHARMACOLOGY, 2014, 28 (03) :179-203

[2] Attention-deficit/hyperactivity disorder in adults: An overview [J].

Faraone, SV ;

Biederman, J ;

Spencer, T ;

Wilens, T ;

Seidman, LJ ;

Mick, E ;

Doyle, AE .

BIOLOGICAL PSYCHIATRY, 2000, 48 (01) :9-20

[3] Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: A randomized, controlled, Phase III trial [J].

Hervas, Amaia ;

Huss, Michael ;

Johnson, Mats ;

McNicholas, Fiona ;

van Stralen, Judy ;

Sreckovic, Sasha ;

Lyne, Andrew ;

Bloomfield, Ralph ;

Sikirica, Vanja ;

Robertson, Brigitte .

EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2014, 24 (12) :1861-1872

[4]

NICE clinical guidelines CG72, 2008, NICE CLIN GUID CG72

[5] The worldwide prevalence of ADHD: A systematic review and metaregression analysis [J].

Polanczyk, Guilherme ;

de Lima, Mauricio Silva ;

Horta, Bernardo Lessa ;

Biederman, Joseph ;

Rohde, Luis Augusto .

AMERICAN JOURNAL OF PSYCHIATRY, 2007, 164 (06) :942-948

[6] Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine [J].

Roskell, N. S. ;

Setyawan, J. ;

Zimovetz, E. A. ;

Hodgkins, P. .

CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (08) :1673-1685

[7] The Changing Prevalence of Attention-Deficit/Hyperactivity Disorder and Methylphenidate Prescriptions A Study of Data From a Random Sample of Insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007 [J].

Schubert, Ingrid ;

Koester, Ingrid ;

Lehmkuhl, Gerd .

DEUTSCHES ARZTEBLATT INTERNATIONAL, 2010, 107 (36) :615-U22

[8]

Stuhec M., 2015, FARMACEVTSKIVESTNIK, V66, P177

[9] Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion [J].

Stuhec, Matej ;

Munda, Barbara ;

Svab, Vesna ;

Locatelli, Igor .

JOURNAL OF AFFECTIVE DISORDERS, 2015, 178 :149-159

[10] Prevalence and incidence of attention-deficit/hyperactivity disorder in Slovenian children and adolescents: a database study from a national perspective [J].

Stuhec, Matej ;

Svab, Vesna ;

Locatelli, Igor .

CROATIAN MEDICAL JOURNAL, 2015, 56 (02) :159-165

← 1 2 →